Functional Collaboration of Insulin-Like Growth Factor-1 Receptor (IGF-1R), but Not Insulin Receptor (IR), With Acute GH Signaling in Mouse Calvarial Cells

被引:10
|
作者
Gan, Yujun [1 ]
Paterson, Andrew J. [1 ]
Zhang, Yue [1 ]
Jiang, Jing [1 ]
Frank, Stuart J. [1 ,2 ,3 ,4 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA
[4] Vet Affairs Med Ctr, Med Serv, Endocrinol Sect, Birmingham, AL 35233 USA
基金
美国国家卫生研究院;
关键词
1ST; 3; DOMAINS; HORMONE RECEPTOR; SOMATOMEDIN HYPOTHESIS; PROSTATE CARCINOGENESIS; SPECIFICITY; OSTEOBLASTS; DISRUPTION; RAT; TRANSCRIPTION; DETERMINANTS;
D O I
10.1210/en.2013-1732
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
GH signals through the GH receptor (GHR), a cytokine receptor linked to Janus kinase 2 (JAK2). GH activates signal transducer and activator of transcription 5 (STAT5), causing expression of genes including IGF-I. IGF-I binds IGF-I receptor (IGF-IR), a heterotetrameric (alpha(2)-beta(2)) tyrosine kinase growth factor receptor similar to insulin receptor (IR). In addition to this GH -> GHR -> IGF-I -> IGF-IR pathway, GH induces a complex including GHR, JAK2, and IGF-IR and deletion of floxed IGF-1R in primary murine calvarial cells with Cre-recombinase-expressing adenovirus (Ad-Cre) desensitizes cells to GH for STAT5 activation and IGF-I mRNA accumulation. Diminished GH-induced STAT5 phosphorylation in Ad-Cre-treated cells is rescued by adenoviruses encoding either IGF-IR or IGF-IR lacking the alpha-chain intracellular domain. Reasoning that IGF-IR's extracellular portion (alpha or extracellular beta) mediates functional interaction with GH signaling, we pursued reconstitution studies. Although structurally related to IGF-IR, IR expressed adenovirally did not rescue GH-induced STAT5 phosphorylation in Ad-Cre-treated cells. We thus created chimeras, swapping homologous IR extracellular regions into IGF-IR. IR and IGF-IR possess N-terminal L1, cysteine-rich (CR), and L2 alpha-chain domains. We created Ad-IGF-IR/IR-L1 and Ad-IGF-IR/IR-L1-CR-L2, in which L1 alone or L1, CR, and L2 of IR replace corresponding IGF-IR regions, respectively. Ad-IGF-IR/IR-L1, but not Ad-IGF-IR/IRL1- CR-L2, rescued GH-induced STAT5 phosphorylation in Ad-Cre-treated cells. Additionally, medium containing a soluble IGF-IR (including only L1-CR-L2) dampened GH-induced STAT5 phosphorylation in calvarial cells and two other GH-responsive cell lines. Thus, an extracellular determinant(s), likely in CR-L2, specifically allows IGF-IR to collaborate with GHR and JAK2 for robust GH-induced acute STAT5 phosphorylation.
引用
收藏
页码:1000 / 1009
页数:10
相关论文
共 50 条
  • [31] Insulin-like growth factor-1 receptor (IGF-1R) expression in liposarcoma as a potential target for therapy. A pilot study
    Mourad, W. A.
    DiFrancesco, L.
    [J]. TUMOR BIOLOGY, 2012, 33 : 105 - 105
  • [32] Functional insulin-like growth factor-1/insulin-like growth factor-1 receptor-mediated circuit in human and murine thymic epithelial cells
    Coelho, VDM
    Villa-Verde, DMS
    Farias-De-Oliveira, DA
    de Brito, JM
    Dardenne, M
    Savino, W
    [J]. NEUROENDOCRINOLOGY, 2002, 75 (02) : 139 - 150
  • [33] Polymorphisms of insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) contribute to pathologic progression in childhood IgA nephropathy
    Hahn, Won-Ho
    Suh, Jin-Soon
    Cho, Byoung-Soo
    [J]. GROWTH FACTORS, 2011, 29 (01) : 8 - 13
  • [34] Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: A novel approach for overcoming resistance in anticancer treatment
    Tandon, Ruchi
    Kapoor, Shweta
    Vali, Shireen
    Senthil, V.
    Nithya, D.
    Venkataramanan, R.
    Sharma, Ashish
    Talwadkar, Anay
    Ray, Abhijit
    Bhatnagar, Pradip K.
    Dastidar, Sunanda G.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 667 (1-3) : 56 - 65
  • [35] The insulin like growth factor-1 receptor (IGF-1R) as a drug target:: novel approaches to cancer therapy
    Bähr, C
    Groner, B
    [J]. GROWTH HORMONE & IGF RESEARCH, 2004, 14 (04) : 287 - 295
  • [36] Targeting insulin-like growth factor-1 receptor (IGF1R) for brain delivery of biologics
    Alata, Wael
    Yogi, Alvaro
    Brunette, Eric
    Delaney, Christie E.
    van Faassen, Henk
    Hussack, Greg
    Iqbal, Umar
    Kemmerich, Kristin
    Haqqani, Arsalan S.
    Moreno, Maria J.
    Stanimirovic, Danica B.
    [J]. FASEB JOURNAL, 2022, 36 (03):
  • [37] Insulin, insulin-like growth factor-1, insulin receptor, and insulin-like growth factor-1 receptor expression in the chick eye and their regulation with imposed myopic or hyperopic defocus
    Penha, Alexandra Marcha
    Schaeffel, Frank
    Feldkaemper, Marita
    [J]. MOLECULAR VISION, 2011, 17 (162): : 1436 - 1448
  • [38] Expression of insulin growth factor-1 receptor (IGF-1R) is associated with cancer stem-like cells and tumor microenvironment
    Joonsalu, M.
    Kase, M.
    Minajeva, A.
    Junninen, J.
    Metsaots, T.
    Niinepuu, K.
    Vardja, M.
    Kase, S.
    Asser, T.
    Jaal, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S588 - S588
  • [39] Overexpression of the insulin-like growth factor 1 receptor (IGF-1R) is associated with malignancy in familial pheochromocytomas and paragangliomas
    Celia Fernandez, Maria
    Martin, Ayelen
    Venara, Marcela
    de Lujan Calcagno, Maria
    Sanso, Gabriela
    Quintana, Silvina
    Chemes, Hector E.
    Barontini, Marta
    Pennisi, Patricia A.
    [J]. CLINICAL ENDOCRINOLOGY, 2013, 79 (05) : 623 - 630
  • [40] Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus -: Altered signaling response to estradiol in the IGF-1m/m mouse
    Richards, RG
    Walker, MP
    Sebastian, J
    DiAugustine, RP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (19) : 11962 - 11969